Figure 4
From: Protection studies of an excretory–secretory protein HcABHD against Haemonchus contortus infection
Dynamics of serum anti-rHcABHD IgG and serum total IgG levels in active and passive immunization trials. Blood samples were obtained at various timepoints from goats in the unchallenged adjuvant group (Group A), challenged vaccinated group (Group B) and challenged adjuvant group (Group C), unchallenged control group (Group D), challenged immunized group (Group E) and challenged control group (Group F), and serum samples were harvested and assayed for the determination of serum anti-rHcABHD IgG and total IgG levels. A Dynamics of serum anti-rHcABHD IgG levels in Trial 1. B Dynamics of serum anti-rHcABHD IgG levels in Trial 2. C Dynamics of serum total IgG levels in Trial 1. D Dynamics of serum total IgG levels in Trial 2. Each data point denoted the mean serum antibody levels (mean ± SD, n = 5 for each group) and asterisks represented statistically significant differences compared to Group C in Trial 1 (*P < 0.05 and ****P < 0.0001) and compared to Group F in Trial 2 (*P < 0.05 and ****P < 0.0001), respectively.